Two fresh ways to play the weight loss and megacap tech hype
A major exchange-traded fund provider is going deep on two popular plays: megacap tech and weight loss drug stocks. Source
Read More
Weight loss diets
Eli Lilly’s Zepbound is off to a strong start, but here’s what needs to happen to push shares higher
Investors will be tuning into the company's fourth quarter earnings call on Feb. 6, eager to hear more about how
Read More
The Ozempic effect has battered this weight loss stock, but Morgan Stanley says it’s a top pick
Despite an 11% dive in the stock Friday, Morgan Stanley said it thinks the company "has gone through an incredible
Read More
‘Miracle drug’ euphoria: Experts warn widespread use of weight loss medicine faces major hurdles
Two experts see major challenges facing the adoption of Novo Nordisk and Eli Lilly's obesity drugs. Source link
Read More
Investors bet on obesity drugs before without much success. Why this next wave could be different
New obesity treatments are helping patients lose 15% or more of their body weight, and changing attitudes could expand access
Read More